Phase 1 N=254 Home Safety Clinical Trial for Alzheimer's Disease
Alzheimer's Disease · Dementia
Primary: Caregiver Strain — 5.95; 6.96 units on a scale — p=<0.0001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=92 Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
Idiopathic Thrombocytopenic Purpura
Primary: Number of Participants Achieving a Platelet Count >=50 Giga Cells Per Liter (Gi/L) for at Least 6 Out of 8 Weeks, Between Weeks 5 and 12 of Part 1 — 1; 25 Participants…
Phase 2 N=90 A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016)
Hepatitis C
Primary: Percentage of Participants Achieving Rapid Viral Response — 86.4; 95.0; 76.2; 20.0 Percentage of participants — p=<0.001
N/A N=5,012 HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.
HIV/AIDS · Sexually Transmitted Infections
Primary: STI Incidence — 250; 226 participants
N/A N=50 Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System
Sensorineural Hearing Loss
Primary: Consonant Nucleus Consonant (CNC) Monosyllabic Word Score-Treated Ear (CO-PRIMARY) — 65.4 percentage of words correct
N/A N=25 Qualitative Assessment of Implementing Routine Rapid HIV Testing
HIV Infections
Primary: Number of Participants Who Completed the Survey — 25 participants
Phase 4 N=87 A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.
Liver Transplantation
Primary: Percentage of Participants With Decrease in Glomerular Filtration Rate (GFR) of Greater Than 20% — 5.4; 0.0 percentage of participants — p=0.494
N/A N=31 Study Protocol for CTS and Keyboard Controlled Randomized Trial
Carpal Tunnel Syndrome
Primary: Length of Time Typing QWERTY Prior to Experiencing Symptoms of CTS (Carpal Tunnel Syndrome) — 71.063 minutes
Phase 1 N=60 A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of Vaniprevir (MK-7009-005)
Hepatitis C
Primary: Area Under the Curve (AUC) (0-infinity) of Vaniprevir in Blood Plasma Following Single Dose Administration — 2.68; 1.48; 5.09; 1.64 µM.hr
Phase 2 N=5 G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer
Lung Cancer
Primary: Number of Patients With Grade 3-4 Febrile Neutropenia During Concurrent Chemoradiotherapy — 0 Participants
Phase 1 N=12 Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
Schizophrenia · Dual Diagnosis · Schizoaffective Disorder
Primary: fMRI Connectivity of Regions of Interest (ROI) Within the Brain Reward Circuitry (BRC). — .40; .33 Z score
Phase 3 N=365 A Study to Compare a New Eye Drop Formulation With Refresh Contacts®
Contact Lens Lubrication
Primary: Percentage of Participants With Contact Lens Distance Visual Acuity Change From Baseline — 11.1; 10.7; 88.9; 88.4 percentage of participants
Phase 2 N=45 A Study of Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028)
Hepatitis C, Chronic
Primary: Number of Participants Who Experienced an Adverse Event — 21; 23 Participants
N/A N=46 PRospective Evaluation of Electrocardiographic Voltage Changes and Six Minute Walk Test for Predicting Readmissions in Heart Failure (PREEMT-HF Study)
Heart Failure
Primary: Emergency Room Visit or Hospitalization for Acute Decompensated Heart Failure (ADHF) — 20 participants
Phase 3 N=87 Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520)
Perennial Allergic Rhinitis
Primary: Percentage of Participants Who Experience at Least One Adverse Event (AE) — 74.5; 55.6 Percentage of participants